QURE

uniQure N.V.
Data: 2026-08-24

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Quick Stats
Aug 24, 2026

49.6

AI Score

HOLD

0.31

Volume Ratio

TBA

Next Earnings

16

+ve Days (30d)

14

-ve Days (30d)

QURE Stock Summary

Last updated Aug 24, 2026

QURE is currently trading at $47.17, positioned above its 200-day moving average of $27.49, indicating a long-term uptrend. The stock has a 52-week range of $8.73 to $71.5.

Technical Analysis: The 50-day moving average stands at $43.13, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 56.648, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.183, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates QURE at 49.6/100 with a HOLD recommendation.

QURE (uniQure N.V.) Indicators

Last updated Aug 24, 2026

Indicator Value
RSI(14) 56.648
CMF (20) 0.183
ROC (10) 1.107
ADX (14) 26.215
Indicator Value
MACD (12,26,9) 2.076
AROONOSC (14) 92.857
WILLAMS %R (14) -49.434
MFI (14) 72.567
QURE Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

QURE Price vs Max Options Open Interest
QURE Max Change In Options Open Interest

QURE Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

QURE Daily Out of Money Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

QURE Daily In the Money Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

QURE Most Active Options by Volume(near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

uniQure N.V. is above both the 50 Day and 200 Day SMA which is considered Bullish.

QURE Moving Averages Analysis

uniQure N.V. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 24, 2026

uniQure N.V. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 24, 2026

QURE (uniQure N.V.) Simple Moving Averages

Moving Averages are last updated Aug 24, 2026

Days MA
10 47.43
20 45.34
30 43.52
50 43.13
100 32.7
200 27.49

QURE Fundamental Analysis

P/E (Forward) 27.933
P/E (Trailing) --
Market Cap ($) 3.4 billion
Earnings/Share ($) -4.06
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -3.4393
EPS Estimate Next Year ($) -2.5944
WallStreet Target Price ($) 69.70
Most Recent Quarter